MET and cancer: Another study by Kanteti et al. (2009) demonstrated that elevated levels of PAX5 expression in small-cell lung cancer induced the expression and activation of the c-MET proto-oncogene, also known as the Hepatocyte Growth Factor Receptor and a potent regulator of cancer cell motility and angiogenesis [94].